These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29568639)

  • 21. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
    Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
    AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the Minimental State Examination Scale and the International HIV Dementia Scale in Assessing Cognitive Function in Nigerian HIV Patients on Antiretroviral Therapy.
    Oshinaike OO; Akinbami AA; Ojo OO; Ojini IF; Okubadejo UN; Danesi AM
    AIDS Res Treat; 2012; 2012():581531. PubMed ID: 23050130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two screening tests for HIV-Associated Neurocognitive Disorder suspected Japanese patients with respect to cART usage.
    Kami-Onaga K; Tateyama M; Kinjo T; Parrott G; Tominaga D; Takahashi-Nakazato A; Nakamura H; Tasato D; Miyagi K; Maeda S; Arae H; Uehara H; Miyagi K; Haranaga S; Fujita J
    PLoS One; 2018; 13(6):e0199106. PubMed ID: 29902251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV.
    Trunfio M; De Francesco D; Vai D; Medina C; Milesi M; Domini S; Alcantarini C; Imperiale D; Bonora S; Di Perri G; Calcagno A
    AIDS Behav; 2022 Jul; 26(7):2203-2211. PubMed ID: 34982319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
    Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
    HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya.
    Mohamed AA; Oduor C; Kinyanjui D
    BMC Neurol; 2020 Jul; 20(1):280. PubMed ID: 32664858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study.
    Atashili J; Gaynes BN; Pence BW; Tayong G; Kats D; O'donnell JK; Ndumbe PM; Njamnshi AK
    BMC Neurol; 2013 Jul; 13():86. PubMed ID: 23855622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of HIV-Associated Neurocognitive Disorder (HAND) among Patients Attending a Tertiary Health Facility in Northern Nigeria.
    Yusuf AJ; Hassan A; Mamman AI; Muktar HM; Suleiman AM; Baiyewu O
    J Int Assoc Provid AIDS Care; 2017; 16(1):48-55. PubMed ID: 25331222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determining the Neurocognitive Status and the Functional Ability of Patients to Screen for HIV-Associated Neurocognitive Disorder (HAND).
    Agarwal R; Aujla RS; Gupta A; Kumar M
    Dement Neurocogn Disord; 2020 Mar; 19(1):19-27. PubMed ID: 32174047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon.
    Njamnshi AK; Bissek AC; Ongolo-Zogo P; Tabah EN; Lekoubou AZ; Yepnjio FN; Fonsah JY; Kuate CT; Angwafor SA; Dema F; Njamnshi DM; Kouanfack C; Djientcheu Vde P; Muna WF; Kanmogne GD
    J Neurol Sci; 2009 Oct; 285(1-2):149-53. PubMed ID: 19631349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International HIV Dementia Scale for HIV-Associated Neurocognitive Disorders: A Systematic Review and Meta-Analysis.
    Rosca EC; Tadger P; Cornea A; Tudor R; Oancea C; Simu M
    Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34202994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validity of the International HIV dementia scale in Brazil.
    Rodrigues RA; Oliveira RL; Grinsztejn B; Silva MT
    Arq Neuropsiquiatr; 2013 Jun; 71(6):376-9. PubMed ID: 23828527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND.
    Chalermchai T; Valcour V; Sithinamsuwan P; Pinyakorn S; Clifford D; Paul RH; Tipsuk S; Fletcher JL; Degruttola V; Ratto-Kim S; Hutchings N; Shikuma C; Ananworanich J;
    J Neurovirol; 2013 Apr; 19(2):137-43. PubMed ID: 23483520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study.
    Kinai E; Komatsu K; Sakamoto M; Taniguchi T; Nakao A; Igari H; Takada K; Watanabe A; Takahashi-Nakazato A; Takano M; Kikuchi Y; Oka S;
    J Neurovirol; 2017 Dec; 23(6):864-874. PubMed ID: 28971376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for HIV-associated dementia in South Africa: potentials and pitfalls of task-shifting.
    Robbins RN; Remien RH; Mellins CA; Joska JA; Stein DJ
    AIDS Patient Care STDS; 2011 Oct; 25(10):587-93. PubMed ID: 21919734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profile of HIV/AIDS Neurocognitive Impairment among HIV Positive Patients in North Central Nigeria.
    Osaigbovo OG; Ugoya S; Ogunniyi A
    West Afr J Med; 2015; 34(3):179-184. PubMed ID: 28276043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic utility of the HIV dementia scale and the international HIV dementia scale in screening for HIV-associated neurocognitive disorders among Spanish-speaking adults.
    López E; Steiner AJ; Smith K; Thaler NS; Hardy DJ; Levine AJ; Al-Kharafi HT; Yamakawa C; Goodkin K
    Appl Neuropsychol Adult; 2017; 24(6):512-521. PubMed ID: 27712132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary trends in HIV-associated neurocognitive disorders in Ghana.
    Sarfo FS; Kyem G; Asibey SO; Tagge R; Ovbiagele B
    Clin Neurol Neurosurg; 2021 Nov; 210():107003. PubMed ID: 34715557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery.
    de Almeida SM; Kamat R; Cherner M; Umlauf A; Ribeiro CE; de Pereira AP; Franklin D; Heaton RK; Ellis RJ
    J Acquir Immune Defic Syndr; 2017 Mar; 74(3):332-338. PubMed ID: 27828876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.